Regarding the breast, very few studies have addressed the potential pro-tumorigenic role of PRMT5, despite high PRMT5 expression being associated with breast cancer progression, aggressive disease, and poor prognosis (Chen et al., 2017, Powers et al., 2011, Yang et al., 2015). The gene discussed is PRMT5; the disease is breast carcinoma.